摘要
63例早期糖尿病肾病患者,随机分为对照组和伊贝沙坦组。治疗12周,伊贝沙坦组HbA1c、尿白蛋白排泄率、尿β2微球蛋白、血清一氧化氮和血浆内皮素1水平均有明显下降,提示伊贝沙坦可延缓糖尿病患者肾功能损害。
Sixty-three type 2 diabetic patients with early diabetic nephropathy were randomly divided into control group and irbesartan treatment group. HbA_(1c), urinary albumin excretion rate and urinary β_(2)-microglobulin excretion, serum nitric oxide and plasma endothelin-1 levels in irbesartan treatment group were significantly decreased after 12 weeks treatment.
出处
《中华内分泌代谢杂志》
CAS
CSCD
北大核心
2004年第4期328-329,共2页
Chinese Journal of Endocrinology and Metabolism
